Proximal femur bone mineral density in osteoporotic patients a review of placebo groups in clinical trials

descriptionPublicationkeyboard_double_arrow_right Conference object , Other literature type , Article 01 Jan 2022 English Publisher:ZenodoJournal:ISW Zenodo repositoryFunded by:EC | CompBioMed2, EC | ISW

Authors: Oliviero, Sara;

doi: 10.5281/zenodo.7248963 , 10.5281/zenodo.7248964

Proximal femur bone mineral density in osteoporotic patients a review of placebo groups in clinical trials

- Summary
- Subjects
- Metrics

Abstract

The aim of this study was to perform a systematic review of Bone Mineral Density (BMD) loss measured in placebo groups of clinical trials for osteoporosis drug treatments. The data collected will be used to characterise bone loss in the populations typically recruited for interventional trials, and to simulate the disease progression in In Silico trials.

Related Organizations

Alma Mater Studiorum University of Bologna
Italy

Keywords

clinical trial, osteoporosis

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average